Areteia Therapeutics

Drug Discovery · Chapel Hill, NC · Founded 2022 · Out of Business

Developer of an oral medication intended to treat eosinophilic asthma. Areteia Therapeutics is based in Chapel Hill, NC and was founded in 2022. Its last known valuation is $1.3 billion (Feb 2024). It has raised $425 million across 2 recorded rounds; the latest was a $425 million Series A1 in Feb 2024.

Last price · $/share
—
Implied valuation
$1.3B
Total raised
$425.0M
Last round
Early Stage VC (Series A1)
Feb 2024
How much has Areteia Therapeutics raised?
$425.0Macross 2 recorded rounds · Jun 2022 – Feb 2024

Most recently, Areteia Therapeutics raised $425.0M in its Early Stage VC (Series A1) (Feb 2024).

Free account
More of Areteia Therapeutics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Areteia Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Areteia Therapeutics round by round

2 rounds
Feb 2024Early Stage VC (Series A1)$425.0M▮
+ 1 more investors · free account
Jun 2022Later Stage VC$360.0MSEC filing▮
16 investors participated

How much has Areteia Therapeutics raised?

Areteia Therapeutics has raised $425 million across 2 recorded rounds since 2022. The largest was a $425 million Series A1 in Feb 2024.

Areteia Therapeutics has filed 2 Form Ds with the SEC since 2024, most recently in Feb 2025 ($360 million sold to 16 investors).

Areteia Therapeutics investors

11 investors are on record for Areteia Therapeutics, including Viking Global Investors, GV, ARCH Venture Partners and Marshall Wace. By type, the record holds 3 venture capital firms, 2 hedge funds and 1 asset manager. The Series A1 in Feb 2024 drew 9 investors.

For fundraisers
Raising for a company like Areteia Therapeutics?

11 investors have backed Areteia Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 11 investors →

Frequently asked about Areteia Therapeutics

How much has Areteia Therapeutics raised?
Areteia Therapeutics has raised $425.0M in total across 2 recorded funding rounds.
When was Areteia Therapeutics's last funding round?
Areteia Therapeutics's most recent recorded round was Early Stage VC (Series A1) in Feb 2024, raising $425.0M.